Skip to main content
Equibles

ODDO BHF ASSET MANAGEMENT SAS

Position in RNA — Atrium Therapeutics, Inc.

CIK 1686970 PARIS, I0
Back to RNA Full portfolio

Position in RNA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$606,460
+$3,607 QoQ
Shares Held
45,090
0.0% QoQ
Ownership
0.264%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#54
of 154 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ODDO BHF ASSET MANAGEMENT SAS holds $86,414,579 across 8 Biotechnology names. RNA ranks #7 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ASND
Ascendis Pharma A/S
 128,657 $34,315,395
2 ARGX
Argenx SE
 25,009 $23,202,599
3 ABVX
Abivax S.A.
 81,496 $10,860,156
4 TWST
Twist Bioscience Corp
 88,006 $9,054,057
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 10,151 $5,042,306
6 ALNY
Alnylam Pharmaceuticals, Inc.
 11,074 $3,333,606
7 RNA
Atrium Therapeutics, Inc.
This page 		45,090 $606,460
8
227,386 $0

All Filings in RNA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $606,460 45,090
2026-03-31 $602,853 45,090